EverSource Wealth Advisors’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.1M Sell
5,172
-4,431
-46% -$870K 0.04% 333
2026
Q1
$1.88M Buy
9,603
+3,647
+61% +$709K 0.06% 226
2025
Q4
$1.03M Sell
5,956
-67
-1% -$12.2K 0.04% 332
2025
Q3
$1.15M Sell
6,023
-3
-0% -$532 0.05% 281
2025
Q2
$1.08M Buy
6,026
+525
+10% +$91.2K 0.05% 258
2025
Q1
$931K Buy
5,501
+224
+4% +$36.8K 0.05% 261
2024
Q4
$796K Buy
5,277
+20
+0.4% +$3.11K 0.04% 277
2024
Q3
$816K Buy
5,257
+21
+0.4% +$3.14K 0.05% 248
2024
Q2
$745K Buy
5,236
+31
+0.6% +$4.25K 0.05% 254
2024
Q1
$719K Buy
5,205
+12
+0.2% +$1.56K 0.06% 226
2023
Q4
$716K Sell
5,193
-4
-0.1% -$526 0.07% 203
2023
Q3
$633K Sell
5,197
-345
-6% -$46K 0.07% 202
2023
Q2
$779K Buy
5,542
+16
+0.3% +$2.21K 0.09% 186
2023
Q1
$782K Buy
5,526
+3
+0.1% +$429 0.1% 163
2022
Q4
$864K Sell
5,523
-2,166
-28% -$311K 0.13% 130
2022
Q3
$943K Buy
7,689
+7,565
+6,101% +$996K 0.22% 84
2022
Q2
$16K Buy
124
+6
+5% +$818 ﹤0.01% 888
2022
Q1
$16K Buy
118
+67
+131% +$9.34K ﹤0.01% 786
2021
Q4
$9K Buy
+51
New +$7.76K ﹤0.01% 993

Other funds holding DGX

EverSource Wealth Advisors's DGX Position: Q2 2026 in Review

EverSource Wealth Advisors reduced its Quest Diagnostics (DGX) stake by 46% in Q2 2026, selling an estimated $870K and leaving 5,172 shares worth $1.1M. The position accounts for 0.04% of the portfolio, ranked #333.

EverSource Wealth Advisors first reported a position in DGX in Q4 2021 and has held it in 19 quarters since. The position peaked at $1.88M in Q1 2026. 1,100 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

  • EverSource Wealth Advisors held 5,172 shares of Quest Diagnostics worth $1.1M as of Q2 2026.
  • EverSource Wealth Advisors sold 4,431 Quest Diagnostics shares in Q2 2026, an estimated $870K.
  • Quest Diagnostics made up 0.04% of EverSource Wealth Advisors's portfolio in Q2 2026, its #333 holding.
  • EverSource Wealth Advisors first reported a position in Quest Diagnostics in Q4 2021 and has held it in 19 quarters since.
  • EverSource Wealth Advisors's Quest Diagnostics position peaked at $1.88M in Q1 2026.
  • 1,100 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on EverSource Wealth Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.